Hepatitis C Virus (HCV) NS3 Sequence Diversity and Antiviral Resistance-Associated Variant Frequency in HCV/HIV Coinfection

HIV coinfection accelerates disease progression in chronic hepatitis C and reduces sustained antiviral responses (SVR) to interferon-based therapy. New direct-acting antivirals (DAAs) promise higher SVR rates, but the selection of preexisting resistance-associated variants (RAVs) may lead to virolog...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Jabara, Cassandra B., Hu, Fengyu, Mollan, Katie R., Williford, Sara E., Menezes, Prema, Yang, Yan, Eron, Joseph J., Fried, Michael W., Hudgens, Michael G., Jones, Corbin D., Swanstrom, Ronald, Lemon, Stanley M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2014
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4187920/
https://ncbi.nlm.nih.gov/pubmed/25092699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03466-14
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi